Italy: Market for Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses 2024

Market Size for Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses in Italy

The Italian human and animal blood market surged to $X in 2022, rising by X% against the previous year. In general, consumption saw prominent growth. As a result, consumption attained the peak level and is likely to continue growth in the immediate term.

Production of Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses in Italy

In value terms, human and animal blood production contracted to $X in 2022 estimated in export price. Over the period under review, production saw buoyant growth. The pace of growth was the most pronounced in 2014 when the production volume increased by X%. Over the period under review, production hit record highs at $X in 2018; however, from 2019 to 2022, production failed to regain momentum.

Join Us at HANNOVER MESSE 2024

Don’t miss your chance to connect with us directly. Schedule a personal meeting to dive deeper into how solutions.
Hall 002, Stand C10. 22 - 26 April 2024 | Hannover, Germany

Book Your Meeting

Exports of Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses

Exports from Italy

In 2022, after seven years of growth, there was significant decline in overseas shipments of human blood and animal blood prepared for therapeutic, pophylactic or diagnostic uses, when their volume decreased by X% to X tons. Overall, exports, however, showed resilient growth. The most prominent rate of growth was recorded in 2013 when exports increased by X% against the previous year. The exports peaked at X tons in 2021, and then dropped notably in the following year.

In value terms, human and animal blood exports dropped notably to $X in 2022. In general, exports, however, recorded mild growth. The most prominent rate of growth was recorded in 2013 when exports increased by X%. Over the period under review, the exports attained the peak figure at $X in 2021, and then shrank notably in the following year.

Exports by Country

France (X tons) was the main destination for human and animal blood exports from Italy, with a X% share of total exports. Moreover, human and animal blood exports to France exceeded the volume sent to the second major destination, the United States (X tons), threefold. Austria (X tons) ranked third in terms of total exports with a X% share.

From 2012 to 2022, the average annual growth rate of volume to France stood at X%. Exports to the other major destinations recorded the following average annual rates of exports growth: the United States (X% per year) and Austria (X% per year).

In value terms, the United States ($X) remains the key foreign market for human blood and animal blood prepared for therapeutic, pophylactic or diagnostic uses exports from Italy, comprising X% of total exports. The second position in the ranking was taken by Germany ($X), with a X% share of total exports. It was followed by France, with a X% share.

From 2012 to 2022, the average annual growth rate of value to the United States stood at X%. Exports to the other major destinations recorded the following average annual rates of exports growth: Germany (X% per year) and France (X% per year).

Export Prices by Country

The average human and animal blood export price stood at $X per ton in 2022, dropping by X% against the previous year. In general, the export price continues to indicate a perceptible contraction. The most prominent rate of growth was recorded in 2014 when the average export price increased by X% against the previous year. The export price peaked at $X per ton in 2018; however, from 2019 to 2022, the export prices stood at a somewhat lower figure.

There were significant differences in the average prices for the major external markets. In 2022, amid the top suppliers, the country with the highest price was Germany ($X per ton), while the average price for exports to France ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was recorded for supplies to Germany (X%), while the prices for the other major destinations experienced a decline.

Imports of Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses

Imports into Italy

In 2022, the amount of human blood and animal blood prepared for therapeutic, pophylactic or diagnostic uses imported into Italy dropped sharply to X tons, declining by X% against the year before. In general, imports saw a abrupt shrinkage. The growth pace was the most rapid in 2015 with an increase of X%. Over the period under review, imports reached the peak figure at X tons in 2019; however, from 2020 to 2022, imports stood at a somewhat lower figure.

In value terms, human and animal blood imports declined remarkably to $X in 2022. Over the period under review, imports, however, showed buoyant growth. The most prominent rate of growth was recorded in 2021 with an increase of X%. As a result, imports attained the peak of $X, and then fell rapidly in the following year.

Imports by Country

In 2022, France (X tons) constituted the largest human and animal blood supplier to Italy, with a X% share of total imports. Moreover, human and animal blood imports from France exceeded the figures recorded by the second-largest supplier, Ireland (X tons), twofold. Switzerland (X tons) ranked third in terms of total imports with an X% share.

From 2012 to 2022, the average annual growth rate of volume from France totaled X%. The remaining supplying countries recorded the following average annual rates of imports growth: Ireland (X% per year) and Switzerland (X% per year).

In value terms, Switzerland ($X) constituted the largest supplier of human blood and animal blood prepared for therapeutic, pophylactic or diagnostic uses to Italy, comprising X% of total imports. The second position in the ranking was taken by Ireland ($X), with a X% share of total imports. It was followed by Germany, with a X% share.

From 2012 to 2022, the average annual rate of growth in terms of value from Switzerland amounted to X%. The remaining supplying countries recorded the following average annual rates of imports growth: Ireland (X% per year) and Germany (X% per year).

Import Prices by Country

The average human and animal blood import price stood at $X per ton in 2022, surging by X% against the previous year. Overall, the import price saw a prominent expansion. The pace of growth appeared the most rapid in 2021 when the average import price increased by X% against the previous year. Over the period under review, average import prices reached the maximum in 2022 and is likely to see steady growth in years to come.

There were significant differences in the average prices amongst the major supplying countries. In 2022, amid the top importers, the country with the highest price was Switzerland ($X,509 per ton), while the price for France ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Switzerland (X%), while the prices for the other major suppliers experienced more modest paces of growth.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :